Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients

This study has been completed.
Information provided by (Responsible Party):
Novartis Identifier:
First received: August 10, 2009
Last updated: November 16, 2011
Last verified: November 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2011
  Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)